Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

FDA To Centocor: Show Me The REMS

Dec 22 2008

• By Pamela Taulbee

Related Content

FDA Holds Up Centocor’s Ustekinumab Three Months But Wants No New Trials

Aug 08 2008

FDA Panel Recommends Centocor’s Ustekinumab Approval; Questions Dosing

Jun 23 2008

Additional Topics

BioPharmaceutical

More from Archive

More from Pink Sheet

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window